|
|
Xceed Capital Limited - Comparative Business Analysis Snapshot
Business Description
Xceed Capital Limited Formerly known as Xceed Biotechnology Limited. The Group's principal activities are the developing and commercialising biodegradable polymers, selling chemical products and working with collaborative partners in identifying additional investment opportunities in the Life Science sector. Its businesses are carried out through its two subsidiaries. PolyNovo develops new generation treatments for use in medical devices, while Boron Molecular provides unique building-block compounds and specialist chemistry services to the global pharmaceutical, fine chemicals and materials market.
Competitor Analysis
This analysis compares Xceed Capital Limited with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
